Thomas P. Bradley
Experienced in Hairy Cell Leukemia (HCL)

Dr. Thomas P. Bradley

Oncology
Northwell Health
Northwell Health Florina Cancer Center
475 Seaview Avenue, 
Staten Island, NY 
On Staff At
Clinical Trials:Currently Recruiting for 1 Trial
Offers Telehealth
44 Years of Experience
Experienced in Hairy Cell Leukemia (HCL)
Northwell Health
Northwell Health Florina Cancer Center
475 Seaview Avenue, 
Staten Island, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Thomas Bradley is an Oncologist in Staten Island, New York. Dr. Bradley has been practicing medicine for over 44 years and is rated as an Experienced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are Upper Tract Urothelial Carcinoma (UTUC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, and Bone Marrow Aspiration.

His clinical research consists of co-authoring 4 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has participated in 2 clinical trials in the study of Hairy Cell Leukemia (HCL).

Graduate Institution
New York Medical College|Universidad De Montemorelos Facultad De Medicina, 1982
Residency
NYC Health + Hospitals/Kings County
Specialties
Oncology
Licenses
Internal Medicine in NY
Board Certifications
American Board Of Internal Medicine
American Board Of Internal Medicine/Hematology
American Board Of Internal Medicine/Medical Oncology
Fellowships
State University of NY Health Science Center/Brooklyn
Hospital Affiliations
North Shore University Hospital
Long Island Jewish Medical Center
Hofstra/Northwell School Of Medicine/Nursing
Staten Island University Hospital
Cancer Institute
Languages Spoken
English
Spanish
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health First
  • HMO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MetroPlus Health
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
Northwell Health
  • INSURANCE PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

Northwell Health Florina Cancer Center
475 Seaview Avenue, Staten Island, NY 10305
Call: 718-226-6400

Additional Areas of Focus

Dr. Bradley has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Penile Cancer
Prostate Cancer
Bladder Cancer
Adrenal Cancer
Testicular Cancer

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase II Study of Ipilimumab, Cabozantinib, and Nivolumab in Rare Genitourinary Cancers (ICONIC)
A Phase II Study of Ipilimumab, Cabozantinib, and Nivolumab in Rare Genitourinary Cancers (ICONIC)
Enrollment Status: Recruiting
Publish Date: December 17, 2025
Intervention Type: Procedure, Biological, Drug
Study Drugs: Cabozantinib, Ipilimumab, Nivolumab
Study Phase: Phase 2
A Phase 3 RandOmized Study Comparing PERioperative Nivolumab vs. Observation in Patients With Renal Cell Carcinoma Undergoing Nephrectomy (PROSPER RCC)
A Phase 3 RandOmized Study Comparing PERioperative Nivolumab vs. Observation in Patients With Renal Cell Carcinoma Undergoing Nephrectomy (PROSPER RCC)
Enrollment Status: Active_not_recruiting
Publish Date: December 02, 2025
Intervention Type: Other, Biological, Procedure
Study Drug: Nivolumab
Study Phase: Phase 3
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: November 20, 2025
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Atezolizumab, Cisplatin, Fluorouracil, Gemcitabine, Mitomycin C
Study Phase: Phase 3
PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab Vs. VEGF TKI Cabozantinib With Nivolumab: A Phase III Trial in Metastatic Untreated REnal Cell CancEr [PDIGREE]
PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab Vs. VEGF TKI Cabozantinib With Nivolumab: A Phase III Trial in Metastatic Untreated REnal Cell CancEr [PDIGREE]
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Intervention Type: Other, Procedure, Drug, Biological
Study Drugs: Cabozantinib, Ipilimumab, Nivolumab
Study Phase: Phase 3
A Prospective Observational Cohort Study to Assess MiRNA 371 for Outcome Prediction in Patients with Newly Diagnosed Germ Cell Tumors
A Prospective Observational Cohort Study to Assess MiRNA 371 for Outcome Prediction in Patients with Newly Diagnosed Germ Cell Tumors
Enrollment Status: Active_not_recruiting
Publish Date: February 26, 2025
Intervention Type: Procedure, Other
Duration of Immune Checkpoint Therapy in Locally Advanced or Metastatic Urothelial Carcinoma: a Randomized Phase 3 Non-Inferiority Trial (IMAGINE)
Duration of Immune Checkpoint Therapy in Locally Advanced or Metastatic Urothelial Carcinoma: a Randomized Phase 3 Non-Inferiority Trial (IMAGINE)
Enrollment Status: Active_not_recruiting
Publish Date: January 15, 2025
Intervention Type: Drug
Study Drugs: Pembrolizumab, Nivolumab, Atezolizumab, Durvalumab, Avelumab
Study Phase: Phase 3
View 5 Less Clinical Trials

4 Total Publications

Treatment of Villous Adenoma With Underlying Adenocarcinoma of the Prostatic Urethra Using Combined Chemoradiation: A Case Report.
Treatment of Villous Adenoma With Underlying Adenocarcinoma of the Prostatic Urethra Using Combined Chemoradiation: A Case Report.
Journal: Cureus
Published: July 16, 2024
View All 4 Publications
Similar Doctors
Elite in Hairy Cell Leukemia (HCL)
Dr. Omar I. Abdel-Wahab
Oncology
Elite in Hairy Cell Leukemia (HCL)
Dr. Omar I. Abdel-Wahab
Oncology

Memorial Hematology Lymphoma Group

1275 York Ave, 
New York, NY 
 (14.2 miles away)
212-639-2000
Languages Spoken:
English

Omar Abdel-Wahab is an Oncologist in New York, New York. Dr. Abdel-Wahab is rated as an Elite provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are Reticulohistiocytoma, Hairy Cell Leukemia (HCL), Leukemia, Rosai-Dorfman Disease, and Bone Marrow Aspiration.

Elite in Hairy Cell Leukemia (HCL)
Dr. Jae H. Park
Hematology Oncology | Hematology | Oncology
Elite in Hairy Cell Leukemia (HCL)
Dr. Jae H. Park
Hematology Oncology | Hematology | Oncology

Memorial Hematology Lymphoma Group

1275 York Ave, 
New York, NY 
 (14.2 miles away)
212-639-2000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jae Park is a Hematologist Oncology specialist and a Hematologist in New York, New York. Dr. Park is rated as an Elite provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are Hairy Cell Leukemia (HCL), Acute Lymphoblastic Leukemia (ALL), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant.

Douglas E. Gladstone
Elite in Hairy Cell Leukemia (HCL)
Dr. Douglas E. Gladstone
Oncology | Transplant Surgery
Elite in Hairy Cell Leukemia (HCL)
Dr. Douglas E. Gladstone
Oncology | Transplant Surgery

Northwell Health Center For Advanced Medicine, RJ Zuckerberg Cancer Center

450 Lakeville Road, Entrance B, 
Lake Success, NY 
 (23.5 miles away)
516-734-8900
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Douglas Gladstone is a Transplant Surgeon in Lake Success, New York. Dr. Gladstone is rated as a Distinguished provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are Hairy Cell Leukemia (HCL), Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Bone Marrow Transplant, and Bone Marrow Aspiration.

VIEW MORE HAIRY CELL LEUKEMIA (HCL) DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bradley's expertise for a condition
ConditionClose
    • Distinguished
    • Adult Soft Tissue Sarcoma
      Dr. Bradley is
      Distinguished
      . Learn about Adult Soft Tissue Sarcoma.
      See more Adult Soft Tissue Sarcoma experts
    • Bladder Cancer
      Dr. Bradley is
      Distinguished
      . Learn about Bladder Cancer.
      See more Bladder Cancer experts
    • Chromophobe Renal Cell Carcinoma
      Dr. Bradley is
      Distinguished
      . Learn about Chromophobe Renal Cell Carcinoma.
      See more Chromophobe Renal Cell Carcinoma experts
    • Clear Cell Sarcoma
      Dr. Bradley is
      Distinguished
      . Learn about Clear Cell Sarcoma.
      See more Clear Cell Sarcoma experts
    • Familial Prostate Cancer
      Dr. Bradley is
      Distinguished
      . Learn about Familial Prostate Cancer.
      See more Familial Prostate Cancer experts
    • Familial Wilms Tumor 2
      Dr. Bradley is
      Distinguished
      . Learn about Familial Wilms Tumor 2.
      See more Familial Wilms Tumor 2 experts
    View All 14 Distinguished Conditions
    • Advanced
    • Adrenal Cancer
      Dr. Bradley is
      Advanced
      . Learn about Adrenal Cancer.
      See more Adrenal Cancer experts
    • Atypical Hemolytic Uremic Syndrome (aHUS)
      Dr. Bradley is
      Advanced
      . Learn about Atypical Hemolytic Uremic Syndrome (aHUS).
      See more Atypical Hemolytic Uremic Syndrome (aHUS) experts
    • Choriocarcinoma
      Dr. Bradley is
      Advanced
      . Learn about Choriocarcinoma.
      See more Choriocarcinoma experts
    • Teratoma of the Mediastinum
      Dr. Bradley is
      Advanced
      . Learn about Teratoma of the Mediastinum.
      See more Teratoma of the Mediastinum experts
    • Testicular Cancer
      Dr. Bradley is
      Advanced
      . Learn about Testicular Cancer.
      See more Testicular Cancer experts
    • Experienced
    • Acute Lymphoblastic Leukemia (ALL)
      Dr. Bradley is
      Experienced
      . Learn about Acute Lymphoblastic Leukemia (ALL).
      See more Acute Lymphoblastic Leukemia (ALL) experts
    • Adrenocortical Carcinoma
      Dr. Bradley is
      Experienced
      . Learn about Adrenocortical Carcinoma.
      See more Adrenocortical Carcinoma experts
    • Alveolar Soft Part Sarcoma
      Dr. Bradley is
      Experienced
      . Learn about Alveolar Soft Part Sarcoma.
      See more Alveolar Soft Part Sarcoma experts
    • B-Cell Lymphoma
      Dr. Bradley is
      Experienced
      . Learn about B-Cell Lymphoma.
      See more B-Cell Lymphoma experts
    • Bone Marrow Aspiration
      Dr. Bradley is
      Experienced
      . Learn about Bone Marrow Aspiration.
      See more Bone Marrow Aspiration experts
    • Bone Tumor
      Dr. Bradley is
      Experienced
      . Learn about Bone Tumor.
      See more Bone Tumor experts
    View All 41 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Close
        0 / 1000

        Please provide us with the below insurance information:

                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.